Engineers Gate Manager LP Intra Cellular Therapies, Inc. Transaction History

Engineers Gate Manager LP

$4.86 Billion
Q3 2024

A detailed history of Engineers Gate Manager LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 20,334 shares of ITCI stock, worth $1.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

20,334

Previous 5,078 300.43%

Holding current value

$1.7 Million

Previous $347,000 328.24%

% of portfolio

0.03%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$67.99 - $80.84 $1.04 Million - $1.23 Million	15,256 Added 300.43%	20,334 $1.49 Million
Q2 2024 Aug 14, 2024	SELL	$64.76 - $79.84 $69,552 - $85,748	-1,074 Reduced 17.46%	5,078 $347,000
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $396,004 - $465,398	6,152 New	6,152 $425,000
Q3 2023 Nov 14, 2023	BUY	$52.09 - $64.1 $382,080 - $470,173	7,335 Added 18.49%	47,003 $2.45 Million
Q2 2023 Aug 14, 2023	BUY	$54.67 - $66.44 $1.9 Million - $2.31 Million	34,703 Added 698.95%	39,668 $2.51 Million
Q1 2023 May 15, 2023	SELL	$43.8 - $56.99 $119,442 - $155,411	-2,727 Reduced 35.45%	4,965 $268,000
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $583,090 - $720,427	-13,231 Reduced 63.24%	7,692 $407,000
Q3 2022 Nov 14, 2022	SELL	$42.7 - $59.99 $839,951 - $1.18 Million	-19,671 Reduced 48.46%	20,923 $974,000
Q2 2022 Aug 15, 2022	BUY	$43.0 - $65.64 $1.5 Million - $2.28 Million	34,811 Added 601.95%	40,594 $2.32 Million
Q1 2022 May 16, 2022	BUY	$38.74 - $62.09 $224,033 - $359,066	5,783 New	5,783 $354,000
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $798,875 - $1.18 Million	-27,816 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $815,008 - $1.24 Million	27,816 New	27,816 $1.14 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $187,070 - $258,243	-8,015 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $141,144 - $255,357	8,015 New	8,015 $206,000
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $125,562 - $337,824	-10,200 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $219,179 - $1.16 Million	-30,190 Reduced 74.75%	10,200 $350,000
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $199,583 - $374,853	26,718 Added 195.42%	40,390 $302,000
Q2 2019 Aug 14, 2019	SELL	$10.65 - $14.29 $362,163 - $485,945	-34,006 Reduced 71.32%	13,672 $177,000
Q1 2019 May 15, 2019	BUY	$10.9 - $14.09 $190,063 - $245,687	17,437 Added 57.66%	47,678 $581,000
Q4 2018 Feb 14, 2019	BUY	$10.36 - $20.96 $313,296 - $633,851	30,241 New	30,241 $344,000
Q2 2018 Aug 03, 2018	SELL	$17.33 - $23.4 $1.15 Million - $1.55 Million	-66,308 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$15.16 - $25.49 $559,510 - $940,759	36,907 Added 125.53%	66,308 $1.4 Million
Q4 2017 Feb 01, 2018	BUY	$14.27 - $16.79 $419,552 - $493,642	29,401	29,401 $426,000

Others Institutions Holding ITCI

# of Institutions

379

Shares Held

84.7M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.87B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Intra Cellular Therapies, Inc. Transaction History